Comparative efficacy of different vaccination programs against Newcastle Disease
The objective of this study was to determine the serological differences after 14 weeks of age in laying chickens using four different vaccination programs against Newcastle disease and a control non-vaccinated group against ND, using a commercial ELISA Kit (CIVTEST® AVI NDV).
The results of this trial show the importance of the live vaccines in the vaccination programme, not just because of the cellular immunity but also as a primer to the humoral response. The Hipraviar®S/H120 and the Hipraviar® Clon/H120 have a minimum titre of 10⁶∙⁵ EID50, the higher vaccine titres made a difference in the levels of antibodies.
HIPRA has developed a serial of services englobed under the new GLOBAL HATCHERY HEALTH PROGRAMME (GHHP), the new service for hatcheries that will bring innovation and real-time control of the HEALTH of the hatchery.
Smart Vaccination by HIPRA is a revolutionary concept that combines: A smart vaccine including RFID technology in its label, a vaccination device which ensures precision and efficiency, and a new world of digital solutions in HIPRAlink Vaccination. All these elements are developed internally by HIPRA.
In Poultry, the HIPRA Smart Vaccination is spearheaded by our innovative vaccines GUMBOHATCH®, EVANT® and EVALON® , the medical devices Hipraject® and Hipraspray®, and the professional veterinary app HIPRAlink® Vaccination.
Discover our latest news